Condition: Coronary Artery Disease · Percutaneous Coronary Intervention · Myocardial Ischemia · Sponsor: Federico II University
The aim of the Naples PCI registry is to collect prospective data on baseline clinical, laboratory, and angiographic characteristics of patients undergoing PCI for acute or chronic coronary artery disease. All patients receive clinical follow-up at hospital discharge and at 1-year follow-up with the objective to assess clinical outcomes, including death, cardiovascular death, myocardial infarction, stroke, stent thrombosis, target-lesion and target-vessel revascularization, contrast-induced acute kidney injury, and bleeding events.
This description comes directly from the study's public registry record.
Giovanni Esposito, MD, PhD · +390817463075 · espogiov@unina.it
Raffaele Piccolo, MD, PhD · +390817464325 · rafffaele.piccolo@unina.it
Always discuss trial participation with your own doctor first.
| Department of Advanced Biomedical Sciences | Naples, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05248165